Medicinal plant species for complex therapy of liver and bile- excreting way diseases in chronic intoxications associated with industrial (technogenic) and domestic toxic effects

FIELD: medicine, phytotherapy, chemical-pharmaceutical industry, pharmacy.

SUBSTANCE: invention relates to the development of medicinal species for treatment of liver and bile-excreting way diseases. Agent for treatment and prophylaxis of liver and bile-excreting way diseases in chronic intoxications associated with industrial (technogenic) and domestic toxic effects comprises milk thistle fruits, common immortelle flowers, knot-grass (knotweed) herb, marjoram herb, milfoil herb, motherwort herb, wild rose fruits, flax seeds, alder compound fruits, and fungus Inonotus obliquus taken in the definite ratio of components. Agent is made as a solid formulation (tablet) or syrup. Agent can be milled and packaged in filter-bags. Agent is prepared as dry extract for the following industrial processing. Apart from cholagogue effect the agent elicits antioxidant, expressed membrane-protective, analgesic and anti-inflammatory effects.

EFFECT: valuable medicinal properties of species.

5 cl, 7 tbl

 

The invention relates to medicine, namely to herbal medicine, and can be used for the prevention and treatment of diseases of the liver and biliary tract.

Known official collection choleretic No. 2 (VFS 42-639-77) (immortelle flowers 40%, yarrow herb 20%, peppermint leaves 20%, the fruits of coriander 20%), has a choleretic, anti-inflammatory and antispasmodic action (Great Russian encyclopedia of medicines. M., “Remedium”, 2001). However, it has several disadvantages, in particular no evidence for hepatopancreatitis and antioxidant properties, which makes them complex therapy to use additional drugs are often synthetic hepatic and antioxidants. It is known that the latter inhibit the immune system (Ball et al., 1986).

The prototype is the drug, "Kars", which is a drug that contains active ingredients, milk Thistle fruit and used in acute hepatitis (toxic) for maintenance therapy in chronic liver diseases and cirrhosis of the liver. Hepatoprotective effect “Kars” explain antioxidant activity, as well as the fact that it stimulates the synthesis of protein, normalizes metabolism of phospholipids (Mashkovsky, “Drugs”, 2000). However, the drug “Cars” has no analgesics is siraudin, lipoic and anti-inflammatory action.

The technical result - getting hepatoprotective agents, possessing in addition choleretic and anti-oxidant actions, expressed lipoic, analgeziruushim and anti-inflammatory properties.

The proposed collection, with trade name “Golden” (the collection) (in the form of herbal teas in filter bags, dry extract, in the form of syrup for special purposes, in pill form), contains immortelle flowers, grass knotweed (knotweed), marjoram, yarrow herb, motherwort herb, fruit, milk Thistle, rose hips, flax seeds, stems alder, chaga in the following ratio, wt.%:

immortelle flowers 1.9

grass knotweed (knotweed) 3.2

herb oregano 6.3

yarrow herb 12.6

motherwort herb 3.2

the fruits of milk Thistle 12.6

rosehips 19

flax seeds 3.2

stems alder 19

chaga 19

Part of the collection includes medicinal plants permitted for use in medical practice (Gasparikova the USSR, 11th edition. Vol. 2 - M., 1990, GOST 21908-93, GOST 1994-93, THE 9700-005-26795008-02).

Antioxidant activity collection set in the course of the research as pharmacological property owned by this collection, is manifested through the songs included in the th composition of the medicinal herbs. In the collection are the fruits of milk Thistle are part of the famous drugs “Kars” and “Zelibor”but the fruit of milk Thistle is not used in the GF, which forced us to write THE 9700-005-26795008-02. Other components of the collection - immortelle flowers, herb oregano, yarrow herb, rose hips have choleretic action (Great Russian encyclopedia of medicines. M., “Remedium”, 2001).

Technology of preparation of the collection lies in the fact that each species of medicinal raw materials that meet the requirements of Gosfarmakapei X and XI edition, is crushed to a size of not more than 7 mm (to filter packets from 0.2 to 2 mm). Then medicinal raw materials are weighed and thoroughly mixed in equal parts to a uniform mixture and take off the dust through a sieve with the hole diameter 0.18 mm, the Raw material is crushed for the manufacture of filter bags pack of 2 g in a special heat sealable porous paper machine ARIZ. For preparing dry extracts and syrups special purpose collection is extracted under vacuum (-0,8 ATM) at a temperature of 65±5°C for 2 hours. The syrup is prepared by saturating the obtained extract the dissolved sugar to the concentration of 60-64%, then the syrup is bottled and pasteurized. To obtain dry extract - 5% liquid extract first concentrated using the mouth of ovci the EMC (installation of a membrane concentration) to the concentration of 18-20%, and then the concentrate is dried by spray drying to 95-97% of dry matter, and tightly Packed at 1000 g for further industrial processing. Solid form (tablets) is prepared from the dried extract and excipients for tablet machines.

To prepare aqueous extract at 4.0 g collection pour 200 ml of purified water at room temperature, insist in infundere apparatus for 15 minutes, then cooled at room temperature for 45 min; filter, wring out plant material and add water to the required volume of extract. When an infusion of filter bags (2 g) you must place the filter pack into the Cup, pour 200 ml boiling water, cover and let stand 10-15 minutes dry Extract is suggested for further industrial processing. Syrup special purpose prepares the drink by adding 20-30 ml of syrup in boiled water or tea. Dosage tablets 0.1 g of dry extract per tablet.

The collection action was studied on a painkiller (analgesic) effect on white weinbrenner rats on the model of acetic cramps”, which was induced by single intraperitoneal introduction of 1 ml of 1% acetic acid, was registered the time of their occurrence within 15 minutes. As the comparison drug used analgin of nutrigenomics is about 50 mg/kg In the control group pain syndrome manifested through 4.5 min, the collection was delayed manifestation of pain syndrome of 7.8 min, and analgin of 9.8 minutes Thus, the analgesic action of collecting comparable with the action of dipyrone (PL. 1).

Anti-inflammatory activity collection was tested for antitumor action in the development of carragenine inflammation logged largest emerging swelling on the white weinbrenner rats (table. 2). Drug comparison ortofen reduced exudation by 63.7%, collection of 23.9% from the control.

Lipoic activity collection was shown in a model of acute poisoning with carbon tetrachloride. In the integral test assessed the microviscosity of membranes on the mobility of the fluorescent probe pyrene in erythrocyte membranes (table. 3). The structure of membranes in the pathogenesis of most pathological conditions is violated due to the intensification of lipid peroxidation, in the process in which hydrophobic fatty acid residues of lipids formed hydroperoxide group. The interaction of these groups with other polar structures of membranes increases microviscosity cellular and subcellular membranes, which, consequently, leads to disruption of intracellular metabolism. As can be seen from table 3, the collection in its action took an intermediate position between con the role (intact animals) and untreated. Thus, the collection has a certain lipoic action.

Hepatoprotective activity of the collection has been evaluated in 2 models:

Toxic hepatitis caused daily for 4 days subcutaneous injection of 50% of carbon tetrachloride. The collection was introduced within 4 days, 15 minutes and 2 hours after poisoning. As the comparison drug used hepatoprotector “Zelibor in a dose of 5 mg/kg In the serum was determined by the activity of alanine aminotransferase, aspartate-aminotransferase elevated which indicates damage of the membranes of hepatocytes, and ran thymol turbidity test. Treatment collection resulted in improved biochemical indices and comparable to the reference product “Zelibor” (PL. 4).

In untreated animals with toxic hepatitis increased activity of Alt in 15.1 times, the activity of AST - 10.2 times, thymol test was increased in 7 times. Treatment collection and Siliborum” reduced accordingly, the activity of Alat - 10,56 and 3.9 times, the activity of AST was 5.2 and 2.1 times, reduced the severity of thymol samples whose values exceeded the normal levels in 3.6 and 1.7 times, respectively.

High values of thymol turbidity tests indicate disruption of the functioning of hepatocytes (liver parenchyma). Elevated levels of Alt and AST ascertain the damage to liver cells is K. Pharmacological action of gathering, leading to improvement of biochemical parameters, comparable to the “Siliborum”, allows to make a conclusion about the presence of hepatoprotective activity.

In the second model of acute toxic hepatitis caused by industrial toxicant from the group of hydrazine derivatives. As Comparators served medicines “Kars”, “Heptral” and “Essentiale”. These drugs and the collection was introduced animals. a day and an hour before hepatotoxicant. Recorded survival of animals by days (up to 14 days). Under the action of LD50the toxicant on the 4 day survival of mice was using drugs “Kars” - 100%of fee - 83%, “Heptral” - 66%, “Essentiale” - 50% (Table. 5). As can be seen from table 5, the collection was superior to the known pharmacopoeial hepatoprotectors, “Heptral” and “Essentiale” and was close to the action “Kars”.

More “hard” conditions (“2LD50the toxicant) 4 day survival rate was “Kars” - 53%, collection of 46% (table. 6).

Thus, the collection has hepatoprotective activity.

The antioxidant activity of the collection was estimated by chemiluminescence in vitro and in vivo (Farkhutdinov, Lihovsky, 1995). At a dose of 0.1 mg/ml collecting inhibited more than 50% of free-radical reactions in the system generation of active forms of oxygen in the system per kanogo lipid oxidation in a dose of 1 mg/ml On the illumination of the whole blood, predominantly neutrophilic granulocytes, the collection had a stimulating effect. Generation biooxidation increased by 25.9% (table. 7). It is known that Lomonosovskaya chemiluminescence of neutrophils is closely connected with the myeloperoxidase system and determines bactericidal activity (Horan et al., 1982). Synthetic antioxidant Mexidol, in contrast, suppresses the glow of phagocytes.

The collection was also used in complex therapy with drugs in the rehabilitation of persons exposed to industrial hazards. So for a group of 34 people in the functional state of the autonomic nervous system was prevailing in the original vegetative tone agatonikiiski signs, impaired microcirculation extravascular character. It also reduced the indicators of spontaneous and stimulated chemiluminescence of whole blood.

Table 1.

Analgiziruyuschee a collection action
The name of the collectionThe time of onset of pain, minThe number of writhing
Collection7,8±0,6*11,0±1,4*
“Analgin” (drug comparison)9,8±,8* 10,7±0,9*
Control4,5±0,332,7±3,1
* Differences with the control group statistically significant.
Table 2.

Antioxidative a collection action on the model carragenine inflammation.
The name of the collectionThe amount of swelling after 3 h %The amount of swelling after 24 h, %
Collection48,5±6,638,6±4,8*
“Ortofen” (drug comparison)19,8±0,9*22,7±1,0*
Control54,6±3,750,7±3,9
* Differences with the control group statistically significant.

Table 3.

Effects of drugs on the characteristics of microviscosity membranes of erythrocytes in rats poisoned by carbon tetrachloride
GroupF400F475Kexim(F475/F400)
Control68,1±4,737,3±3,0 0,55□
Untreated88,7±5,330,2±2,10,34*
Collection80,1±4,031,9±2,60,40*
* Differences with the control group statistically significant.

□ Differences with untreated group statistically significant.
Table 4.

Hepatoprotective activity fee (1 model)
Group nameThe activity of Alat, µm/h·mlThe activity of AST, µm/h·mlThymol test, Rel. units
Control0,24±0,03*0,33±0,02*2,1±0,01*
Collectionof 2.51±0,24*1,72±0,32*7,6±0,6*
Zelibor (drug comparison)0,93±0,22*0,68±0,40*3,6±0,4*
Control (untreated)3,62±0,293,36±0,3514,6±0,1
* Differences with the control group statistically significant.

Table 5.

The impact of collection on the survival of mice with acute toxicosis (including steatosis) in the administration of the dose LD50the% protection
Medication1 days4 daysQualitative assessment of medication
Kars100100Protective
Collection8383Activity: expressed
Heptral66,666,6moderate
Essentiale5050not effective
Control5033 
Table 6

The impact of collection on the survival of white mice 2LD50the toxicant, %
Medication1 days4 days
Kars6053
Collection5346
Control00

Table 7.

The influence of different concentrations of collection on the chemiluminescence model systems (in$)
HerbalConcentration, mg/mlThe system generating ROSThe system, initiating the FLOORThe system of phagocytes whole blood
SS% of controlSS% of controlSS% of control
Control014,08±0,03100,0034,91±1,40100,00 100,00
0,018,7±0,362,42*30,65±1,3087,79*  
Collection0,18,62±0,161,35*28,20+0,9080,77*322,8±11,1125,89*
1,06,77±0,0448,08*9,74±0,6027,90* 
* P<0,05.

At the beginning of treatment for removal of perivascular edema was administered aminophylline tablets of 0.15 for 10 days, then piracetam intramuscular injection of 5 ml of 20% solution for 10 days, then in capsules 0.4-0.8 2 times a day up to 1 month. In the future, within 20 days of the prescribed fee in the form of a 2% aqueous extract of 200-300 ml per day.

After 1 year of treatment, consisting of prescribed medication, showed improvement of microcirculation, the tendency to normalization of blood chemiluminescence, more pronounced in regard to spontaneous luminescence. After a course with the use of data collection changes grew more pronounced was the effect of the normalization of the functional reserve faguoqitirute blood cells - differences between indicators setosum stimulated and spontaneous chemiluminescence of whole blood. In 90.3% of patients noted this trend. Immunological indicators also improved - increased the number of T-lymphocytes, including helper-inductors, changed immunoregulatory index by reducing the content of suppressor-cytotoxic cells.

In General, the use of the collection in the complex therapy with drugs had a positive effect on circulation, Central nervous system, free radical Oka the field. The obtained results allow to recommend the collection for the treatment of persons exposed to industrial hazards, as well as in connection with a negative influence on the body most of the workers are functional sub-optimal state, which can be considered as predvoleny.

Thus, the proposed collection may be used in the treatment of diseases of the liver and biliary tract, as well as prevention of chronic intoxications associated with production (man-made) and household toxic effects.

1. For the treatment and prevention of diseases of the liver and biliary tract in chronic intoxications associated with production (man-made) and household toxic effects, containing fruits, milk Thistle, characterized in that it additionally contains immortelle flowers, grass knotweed (knotweed), marjoram, yarrow herb, motherwort herb, fruit trees, flax seeds, stems alder, chaga, in the following ratio, wt.%:

Immortelle flowers 1,9

Grass knotweed (knotweed) 3,2

Herb oregano 6,3

Yarrow herb 12,6

Motherwort herb 3,2

The fruits of milk Thistle 12,6

Rosehips 19,0

Flax seeds 3,2

Stems alder 19,0

Chaga 19,0

2. The tool according to claim 1, characterized in that it is made in the form of solid forms (tablets).

3. The tool according to claim 1, characterized in that it is made in the form of syrup.

4. The tool according to claim 1, characterized in that it is shredded and packaged in filter bags.

5. The tool according to claim 1, characterized in that it is made in the form of a dry extract for further industrial processing.



 

Same patents:

FIELD: medicine, gastroenterology.

SUBSTANCE: a patient should follow a diet along with the intake of cholagogue species, oats decoction and symptomatic therapy. Moreover, at postoperative period a patient should be prescribed with the intake of drinking mineral water named "Ust' Kachkinskaya 1/99" at 38-40 C at total mineralization being 8.2-8.6 g/cu. m 40-60 min before meals 5-6 times daily at total amount of 200-250 ml for 24 d. Diet is fractional, 6 times daily, calorie amount of 2800-3000 kcal and decrease of highly digestible carbohydrates up to 30 g/d. The method enables to avoid application of hepatoprotectors and antioxidants during therapy to prevent polypragmasy.

EFFECT: higher efficiency of rehabilitation.

3 ex

FIELD: medical procedures.

SUBSTANCE: patients preliminarily undergo endoscopic papillo-sphincterotomy, whereupon stone in common bile duct is dissolved and removed by way of supplying stone-dissolving therapeutic mixture, in particular 1:1 solution of diethyl ether in olive oil, directly to bile stone. Therapeutic mixture creates, in the lumen of bile duct, hydrostatic pressure 200 mm water head. More specifically, 120 ml of therapeutic mixture is supplied during one day at a rate of 10 drops/min, while performing 5 to 16 daily sessions of stone-dissolving therapy.

EFFECT: increased efficiency in removal of sparingly soluble stones in common bile duct.

2 ex

FIELD: medicine, hepatology.

SUBSTANCE: the suggested preparation is being polyprenols obtained out of woody greens of coniferous trees, of general formula

known earlier as a hepatoprotector. The innovation keeps organ stromas without any considerable proliferation of connective tissue, activates metabolic processes at no activation of spontaneous pathology (that is affected synthesis of ribosomal RNA and hepatocytic mitosis being not typical for hepatic tissue).

EFFECT: higher efficiency of stimulation.

5 tbl

FIELD: medicine.

SUBSTANCE: method involves crushing hill-growing saltwort herb to 3-10 mm and extracting with 25% ethyl alcohol solution in raw material : solvent proportion of 1:2.6 using percolation method on a battery composed of 6 percolators during 6 h in each of them at room temperature.

EFFECT: increased finished product output.

3 tbl

FIELD: medicine, hepatology.

SUBSTANCE: at achieving alkaline phosphatase of 580 U and more one should introduce ursodesoxycholic acid at the dosage of 15-20 mg/kg and orlistate at the dosage of 90-100 mg twice or thrice daily for patients with steatohepatitis. According to normalization of clinical and biochemical values of blood analyses it is possible to conclude upon successfulness of therapy performed. The method provides clinic-laboratory remission of the disease.

EFFECT: higher efficiency of therapy.

3 ex

FIELD: organic chemistry, medicine, pharmacy.

SUBSTANCE: invention relates to the substituted 4-benzylaminoquinolines and their heteroanalogs of the general formula (I): P-L-G (I) wherein G means compound of the formula: G(I) wherein K means -OR(7), -NH-CH2-CH2-SO3H, -NH-CH2-CO2H wherein R(7) means hydrogen atom, CH3; R1-R6 mean independently of one another hydrogen atom, -OR(10), -R(10) being one of residues R1-R6 means a bond with L always; R(10) means hydrogen atom, (C1-C4)-alkyl; L means (C1-C15)-alkyl being one or some structural CH2-fragments can be replaced for -C≡C-, -NR(11)-, -CO-, -O- wherein R(11) means hydrogen atom; P means: or wherein A means nitrogen atom (N); B means CH; D means CH; E means CH; R16-R24 mean independently of one another hydrogen atom, F, Cl atoms, (C1-C4)-alkyl being alkyl residues can be mono- or multiple-substituted with fluorine atom, NR(25)R(26), OR(25), COR(25), COOR(25), CONR(25)R(26) being one of residues R16-R(24) means a bond with L always; R25 and R26 mean independently of one another hydrogen atom, (C1-C4)-alkyl or benzyl. Also, invention relates to their pharmaceutically acceptable salts. Also, invention relates to a method for their preparing and to a drug based on thereof for prophylaxis of supersaturation of bile with cholesterol. Invention provides preparing new compounds and a drug based on thereof that can be used for prophylaxis and treatment of patients suffering with gallstones.

EFFECT: improved preparing method, valuable medicinal properties of compounds and drugs.

10 cl, 32 ex

"antipsoriaz" cream // 2246935

FIELD: pharmaceutical industry.

SUBSTANCE: invention relates to developing medicaments in the form of ointment based on vegetable components and designed, in particular, to treat psoriasis as well as fungus diseases and can also be used in cosmetology. Psoriasis treatment cream includes water extracts of bur-marigold (Bidens tvipartita), white birch leaves (Betula alba L), greater celandine (Chelidonium majus), calendula (Calendula officanalis L), cudweed (Gnphalium uliginosum L), medical vaseline, lanolin, camphor, linseed oil, and medical solid oil at specified proportions of components.

EFFECT: increased treatment efficiency, avoided use of chemical additives, and prolonged shelf time.

FIELD: organic chemistry, pharmacy.

SUBSTANCE: invention relates to new derivatives of dihydropyrimidine of the general formula (I):

or its isomeric form of the formula (Ia):

that can be used, for example, for treatment and prophylaxis of hepatitis B. In indicated formulas R1 means unsubstituted phenyl or phenyl substituted once or many times with similar or different substitutes taken among the group including halogen atom, trifluoromethyl group, nitro-, amino-group, hydroxyl and alkyl with 1-6 carbon atoms, or residues of formulas:

, or ; R2 means residue of the formula -XR5 wherein X means a bond or oxygen atom; R5 means alkenyl with 2-4 carbon atoms or alkyl with 1-4 carbon atoms that can be unsubstituted or substituted with phenoxy-group; R3 means amino-group, alkyl with 1-4 carbon atoms or cyclopropyl; R4 means pyridyl that is substituted with up to three times with similar or different substitutes taken among the group including halogen atom, trifluoromethyl group, alkoxy-group with 1-6 carbon atoms and alkyl with 1-6 carbon atoms, and their salts. Also, invention relates to 3,5-difluoro-2-pyridincarboxyimidamide and 3,5-difluoro-2-pyridincarbonitrile that can be sued as intermediates products for preparing compounds of the formula (I) or (Ia) and to a medicinal gent.

EFFECT: improved preparing method, valuable medicinal properties of compounds.

10 cl, 2 sch, 4 tbl, 9 ex

FIELD: medicine, surgical gastroenterology.

SUBSTANCE: as a curative preparation one should apply a pectin-containing powder product of table beet out of sublimated raw material. For reducing the powder before application one should apply low-mineralized low-alkaline amicrobial solution of electrochemically activated catholyte. Supernatant transparent fraction of this solution should be constantly introduced by drops into nasobiliary probe, residual fraction should be applied for peroral additional enterosorption. The method provides sanitation of biliary ducts by preventing duodenocholedochous reflux, and enterosorption that decreases portal toxemia.

EFFECT: higher efficiency of therapy.

2 cl, 1 ex

FIELD: medicine, pharmaceutical industry.

SUBSTANCE: invention relates to agents used for treatment of chronic hepatitis. The hepatoprotective agent representing extract prepared from biomass of Maackia amurensis Rupr. et Maxim and obtained by the callus culture method comprises polyphenolic complex consisting of daidzein, retusin, genistein, formononetin, maackianin and medicarpin. The hepatoprotective agent promotes to effective treatment of chronic hepatitis.

EFFECT: valuable medicinal properties of agent.

2 tbl

FIELD: medicine, chemical-pharmaceutical industry.

SUBSTANCE: invention relates to the development of new homeopathic suppository that can be used for treatment of prostatitis, hemorrhoid, uterus cervix erosion, endometritis. Invention proposes two variants. By the first variant agent represents suppository comprising the following components, g: propolis, 0.1; sea-buckthorn, 0.2; chestnut homeopathic essences, 0.1; Ginkgo biloba homeopathic essences, 0.1; aloe homeopathic essences, 0.1; milfoil, 0.1; wax, 0.1 and a base. The second variant represents suppository comprising the following components, g: sea-buckthorn, 0.2; propolis, 0.1; rue homeopathic essences, 0.05; Hypericum (Saint-John's-wort), 0.05; Symphytum (comfrey), 0.05; Tambukan curative muddy extract, 0.2; lanolin, 0.15; wax, 0.1, and a base. Proposed suppository elicits an anti-inflammatory regenerating effect and without toxic effect.

EFFECT: valuable medicinal properties of suppository.

15 cl, 4 ex

FIELD: pharmaceutical industry.

SUBSTANCE: preparation method comprises heating rock oleoresin to specified temperature, forming tape by passing through rolls, and tableting in laminar air flow using, for example, tubular knife with cutting edge sharpening radius no greater than 0.2 mm.

EFFECT: enabled tableting in absence of inert additives at any temperature and moisture characteristics of atmospheric air and enhanced therapeutical effect of rock oleoresin tablets.

2 cl, 3 tbl, 3 ex

FIELD: veterinary science.

SUBSTANCE: one should apply intrapleural novocaine-antibiotic blockade in combination with intramuscular injection of 10%-erancond-B solution at the dosage of 3.0 -3.5 mg/kg body weight for the first 4-5 d of therapy. Calves should be daily given a tincture out of coltsfoot leaves prepared at the ratio of 1 portion of grass per 10 portions of water, at 90 - 110 ml/calf thrice daily. Intake of 0.5 - 0.6 g ascorbic acid should last for 5-7 d. The method provides activation of immune systems, T-system, phagocytic and interferonogenic ones, in particular.

EFFECT: higher efficiency of therapy.

1 ex, 4 tbl

FIELD: veterinary science, gynecology.

SUBSTANCE: one should introduce biogenic stimulants for a sick animal, moreover, not excluding the main therapy, one should once, twice or thrice inject a preparation that contains the components of animal and plant origin as biogenic stimulants into dorsal lumbar muscles from the left and from the right against vertebral column being in the center between the tops of spinous and the ends of cross-costal processes at interval of 5-10 d per a half of curative dose at 0.03-0.05 ml/kg animal body weight at the following ratio, %: sterile aqueous tincture out of cow's udder tissues extracted out of cow's udder stuffing diluted with double quantity of fresh running water 35.61, sterile aqueous tincture out of the tops of stalks, leaves, and tubers of Jerusalem artichoke taken at equal quantities and diluted with double amount of fresh running water 35.61, formalin or phenol-free creolin 0.28, natural bee honey 28.5. Moreover, this preparation should undergo 4-fold thermal treatment for 60 min at 1-d-long interval in water bath at 58-59 C.

EFFECT: higher efficiency of therapy.

1 cl

FIELD: medicine, oncology, chemical-pharmaceutical industry and technology, pharmacy.

SUBSTANCE: tablet with antitumor effect contains acceptable carrier on which the following mixture of aqueous-alcoholic tinctures is applied: bloody geranium, penny-cress, common cocklebur and European wild ginger. Tablets by mass 1 g including slipping substance contains the following amounts of indicated tinctures as measure for dry matters, g: bloody geranium, 0.015-0.020; penny-cress, 0.011-0.015; common cocklebur, 0.011-0.017, and European wild ginger, 0.024-0.036. Method for preparing tablet involves applying on carrier the mixture of aqueous-alcoholic tinctures of above indicated plants, the following drying the prepared mass, its granulating and tableting. Method for prophylaxis and treatment of oncological patients involves prescription 0.5-2 tablets with oncological designation, tree times per a day and the treatment course is determined individually based on objective data of treatment. Tablet made by claimed methods shows complex properties: it delays tumor growth and metastazing and can be recommended for treatment and prophylaxis of oncological pathology both independently and in combination with chemo-radiation therapy. Invention can be used in technology for making medicinal formulations of preparations with oncological designation and for treatment of patients with oncological pathology of different organs and body systems.

EFFECT: improved for making tablet, valuable medicinal properties of tablet.

7 cl, 4 ex

FIELD: medicine, oncology, chemical-pharmaceutical technology, pharmacology, pharmacy.

SUBSTANCE: tablet eliciting the antitumor effect comprises active dose of aconite alkaloids in the amount 0.0125-0.0375 mg. Invention relates to a method for making tablet with antitumor effect. Method involves treatment suitable carrier taken in the amount corresponding to the content of alkaloids in tablet 0.0125-0.0375 mg with aconite tincture wherein amount of the total content of alkaloids is determined preliminary. Then carrier treated by such manner is dried at temperature 30-35°C, not above, granulated, granules are powdered and tableted. Also, invention relates to a method for treatment of oncological patients that involves prescription to patient 0.5-2 tablets with oncological designation being this treatment is determined individually. Invention can be used in manufacturing medicinal formulations of preparations used for treatment of patients with oncological pathology.

EFFECT: improved method for treatment and making, valuable medicinal properties of tablet.

8 cl, 2 ex

FIELD: medicine, pharmacy.

SUBSTANCE: invention relates to curative ointments with anti-inflammatory effect and with biostimulating properties for treatment of burns, suppurative and infected wounds of different etiology and to a method for treatment above said diseases using the ointment said. The proposed ointment comprising bee wax and greasy basis comprises colophony additionally. As greasy basis the ointment comprises butter and vegetable oil in the following ratio of components, wt.-%: bee wax, 20-30; butter, 30-40; vegetable oil, 15-25; colophony, 15-25. Method involves applying ointment by thin layer 0.5-3 mm on dense cotton fabric, its applying to damaged site, keeping and removing ointment with change of bandage 1-3 times per 24 h for 3-14 days. Method provides enhancing the therapeutic effectiveness of ointment due to significant acceleration the healing process of suppurative wounds and insidious furuncles being the ointment doesn't cause irritating effect.

EFFECT: improved and valuable medicinal properties of ointment.

2 cl, 4 ex

FIELD: medicine, endocrinology, physiotherapy.

SUBSTANCE: the present innovation deals with introducing preparations of antioxidant, antiaggregate, antithrombotic and hypolipoedemic action as detralex and sulodexide along with the impact of low-intensity laser radiation (LILR) (at wave length of 0.97 mcm and power of 5-7 W). Moreover, LILR impact should be performed by contact since the 1st d of conservative therapy on projection of the main vessels of lower limbs in, at least, 2 o\points at every of them per 1-2 min/every point, and high-intensity laser radiation (HILR) impact should be carried out by contact-free technique from the distance of 1-3 cm for visually altered part of affected limb's skin in area of trophic disorders up to the border with intact tissue, beginning from toes towards talocrural joint and longitudinally towards knee joint, proximally up to the lower third of femur.

EFFECT: higher efficiency of therapy and decreased traumatism.

1 cl, 2 ex

FIELD: veterinary science.

SUBSTANCE: treatment should be carried out with an extract of walnuts of milk-wax maturity upon kerosene at addition of propolis and pollen perorally as compresses for 2-3 h followed by treating affected surface with mustard-gourd oil named "Volgogradskoe"; moreover, one should introduce perorally per 7-8 ml extract/5 ml liquid for milking twice daily. The present innovation enables to perform valuable body sanitation in more shortened period of time due to activation of immune system and restoration of metabolic body processes.

EFFECT: higher efficiency of therapy.

1 cl, 1 ex

FIELD: medicine.

SUBSTANCE: the present innovation deals with the ways for body purification and detoxication with the help of products of plant origin. The method includes preliminary period at additional survey for the presence of parasites followed by body purification due to curative starvation: during the first day a patient should apply nocturnal purifying enema, next morning - saline purgative preparation, then during the second and next day of starvation it is prescribed the intake of not less than 1-1.5 l water at daily application of purifying enemas for the whole period of starvation, and restorative period at applying juice-fruit-vegetable diet. Moreover, at the background of starvation, one should perform hepatic purification and that of gastro-intestinal tract along with body disinfection and withdrawal of parasites: at 7 p.m. during the 1st d of starvation a patient should apply 150 mg decaris, daily since the 1st d to the 7th d of starvation it is necessary to use decoctions of cholagogue, diuretic and antiparasitic herbal species. Since the 4th d of starvation one should add the intake of garlic decoction based upon milk, on the 3d, 5th, 7th d of starvation it is necessary to fulfill hepatic tubing at 7 p.m. after the intake of natural apple juice at 4 p.m., moreover, on the 3d d of starvation tubing should be conducted after the intake of vegetable oil in lemon juice, 4 times, on the 5th d - after the intake of cholagogue species, 4 times, on the 7th d - after the intake of purgative species with sorbitol. During the 1st d of starvation end one should perform parasitic disinfection due to the intake of acid milk whey to one's empty stomach, in 30-40 min -herring without bread, in 2 h - a glass of warm, sweet milk and application of purifying enema in 6-8 h. The method provides simultaneous restoration of affected body metabolism, hepatic purification and that of gastro-intestinal tract followed by withdrawal of parasites.

EFFECT: higher efficiency of body healing.

6cl, 2 ex, 1 tbl

FIELD: medicine, cardiology, phytotherapy, pharmacy.

SUBSTANCE: invention relates to the field in development of an agent of vegetable origin used for improvement of the functional state and prophylaxis of organic alterations in cardiovascular system, in particular, atherosclerosis. The biologically active supplement used for prophylaxis of cardiovascular diseases, in particular, atherosclerosis comprises clover dry extract, haw-thorn flowers powder, ascorbic and nicotinic acids, and accessory substances taken in the definite ratio. The biologically active supplement is made in the form of tablet or capsule. No adverse responses observed in intake of the supplement. The blood cholesterol level was reduced to the normal value in 68% of patients and reducing morbidity with acute respiratory-viral infections has been noticed. In patients with ischemic heart disease with cholesterolemia the improvement of the state is noted on the background of conventional therapy: the moderate reducing the arterial pressure value in its elevation, improved in the state of health, enhanced working capacity, reduced retrosternal pains, ear noise, vertigo, headache.

EFFECT: valuable medicinal properties of supplement.

1 ex

Up!